Expert View: Transforming biotherapeutic development post-pandemic
Read More
Carterra is streamlining the arduous process of screening new life-saving drugs
Read More
AlphaLISA and HT-SPR together can help you better understand FcRn biology
Read More
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies
Read More
Exploring multicomponent COVID-19 mutant variant analysis of immunity indicators in human serum
Read More
How Josh Eckman launched Carterra and raised $50M in funding
Read More
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential
Read More
Effectively Screen Biotherapeutic Targets Using Carterra’s Powerful Software Suite
Read More
DDW Podcast: The Bamlanivimab story – how it reached the clinic in eight months
Read More
Dousing the Pandemic’s Flames
Read More
